In addition, CD133 has been taken as a prognostic factor of some cancers, such as colon carcinoma, non-small cell lung cancer, hepatocellular carcinoma and cholangiocarcinoma[48-51,53-55]. This evidence concerns the gene PROM1 and colon carcinoma.